Biomerica Inc (BMRA): Total Assets
$6.76M
As of 2026-05-31
-22.4%
3-year compound annual growth
-10.6%
5-year compound annual growth
+1.7%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-05-31 | $6.76M | +13.7% | 2026-08-31, Balance as of period end |
| 2025-05-31 | $5.95M | -35.8% | 2026-08-31, Balance as of period end |
| 2024-05-31 | $9.25M | -36.0% | 2025-08-29, Balance as of period end |
| 2023-05-31 | $14.45M | +27.1% | 2024-08-28, Balance as of period end |
| 2022-05-31 | $11.37M | -3.8% | 2023-08-25, Balance as of period end |
| 2021-05-31 | $11.82M | -31.5% | 2022-08-29, Balance as of period end |
| 2020-05-31 | $17.26M | +229.1% | 2021-10-14, Balance as of period end |
| 2019-05-31 | $5.25M | +0.4% | 2020-08-31, Balance as of period end |
| 2018-05-31 | $5.22M | +4.1% | 2019-08-29, Balance as of period end |
| 2017-05-31 | $5.02M | -12.4% | 2018-08-29, Balance as of period end |
| 2016-05-31 | $5.73M | -6.5% | 2017-08-29, Balance as of period end |
| 2015-05-31 | $6.12M | -5.3% | 2016-08-29, Balance as of period end |
| 2014-05-31 | $6.47M | +1.2% | 2015-08-31, Balance as of period end |
| 2013-05-31 | $6.39M | +14.8% | 2014-08-29, Balance as of period end |
| 2012-05-31 | $5.57M | +12.4% | 2013-08-29, Balance as of period end |
| 2011-05-31 | $4.96M | n/a | 2012-08-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Biomerica Inc (BMRA) | 2026-05-31 | $6.76M | +13.7% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $25.76M | -26.6% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $30.24M | +59.8% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $5.46M | -0.6% |
| Volitionrx Ltd (VNRX) | 2025-12-31 | $6.90M | -26.6% |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | $582.98M | -26.4% |
| Immucell Corp (ICCC) | 2025-12-31 | $42.53M | -5.7% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $103.58M | -12.8% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $842.13M | -29.3% |
Compare BMRA, IMDX, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗